Chethana Medicaments Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.54 M
- Company Age 31 Year, 29 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
- Revenue Growth -40.48%
- Profit Growth -35.40%
- Ebitda 183.76%
- Net Worth 37.37%
- Total Assets 5.57%
About Chethana Medicaments
Chethana Medicaments Pvt Ltd (CMPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 January 1994 and has a history of 31 years. Its registered office is in Malappuram, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.54 M.
The company currently has active open charges totaling ₹2.50 M.
Kunnakkavu Purushothaman, Narayanan Mana, Damodar Avanoor, and Two other members serve as directors at the Company.
Company Details
-
Location
Malappuram, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397KL1994PTC007632
-
Company No.
007632
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jan 1994
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Chethana Medicaments?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunnakkavu Purushothaman
|
Managing Director | 10-Jan-1994 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Narayanan Mana
|
Director | 01-Nov-1995 | Current |
|
Damodar Avanoor
|
Whole-Time Director | 10-Jan-1994 | Current |
|
Avanoormana Nambudiri
|
Whole-Time Director | 10-Jan-1994 | Current |
|
Saraswathy Narayanan
|
Director | 17-Jun-2019 | Current |
Financial Performance of Chethana Medicaments.
Chethana Medicaments Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 40.48% decrease. The company also saw a substantial fall in profitability, with a 35.4% decrease in profit. The company's net worth Soared by an impressive increase of 37.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chethana Medicaments?
In 2021, Chethana Medicaments had a promoter holding of 59.83% and a public holding of 40.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Chethana Formulations Private LimitedKunnakkavu Purushothaman, Damodar Avanoor and 1 more are mutual person
-
Variety Pharmaceuticals Pvt LtdDamodar Avanoor is a mutual person
-
Puthumana Ecofarms Private LimitedKunnakkavu Purushothaman is a mutual person
-
Puthumana Agrofarms Private Limited
Kunnakkavu Purushothaman is a mutual person
-
Chethana Merchandise Private Limited
Kunnakkavu Purushothaman and Damodar Avanoor are mutual person
-
Chelamala Field Latex Producer Company Limited
Narayanan Mana and Damodar Avanoor are mutual person
Charges (Loans)
₹2.50 M
₹0
Charges Breakdown by Lending Institutions
- Dhanlaxmi Bank Limited : 0.24 Cr
- Dhanalakshmi : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | Dhanlaxmi Bank Limited | ₹0.35 M | Open |
| 24 Sep 2018 | Dhanlaxmi Bank Limited | ₹2.00 M | Open |
| 11 Nov 1995 | Dhanalakshmi | ₹0.15 M | Open |
How Many Employees Work at Chethana Medicaments?
Unlock and access historical data on people associated with Chethana Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chethana Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chethana Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
